secwatch.observer — SEC 8-K summary
======================================

Issuer:     TACTILE SYSTEMS TECHNOLOGY INC (TCMD)
CIK:        0001027838
Form:       8-K
Filed at:   2025-05-05T23:59:59+00:00
Accession:  0001558370-25-006292
Event type: earnings
Sentiment:  negative
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Tactile Medical Q1 revenue flat, net loss widens; lowers FY 2025 revenue and EBITDA guidance
--------------------------------------------------------------------------------

- Q1 2025 revenue $61.3M (+0.3% YoY); net loss $3.0M vs $2.2M loss in Q1 2024.
- Adjusted EBITDA loss $0.3M vs positive $1.0M in prior-year quarter.
- Lymphedema product sales -3% YoY; airway clearance +22% YoY.
- FY 2025 revenue guidance lowered to $309-315M (prior $316-322M); EBITDA guidance cut to $32-34M from $35-37M.
- Repurchased $10M of stock in Q1; $16.5M remaining under $30M buyback program.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1027838/000155837025006292/0001558370-25-006292-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1027838/000155837025006292/tcmd-20250505x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-25-006292

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer